down arrow

Astellas Pharma, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3942400007
JPY
2,048.00
28 (1.39%)

Dec 11

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
5,05,794.00
4,59,294.00
5,17,408.00
4,62,497.00
4,73,124.00
4,14,602.00
4,21,932.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,05,794.00
4,59,294.00
5,17,408.00
4,62,497.00
4,73,124.00
4,14,602.00
4,21,932.00
Raw Material Cost
1,27,596.00
1,09,419.00
1,33,493.00
1,16,928.00
1,26,128.00
1,05,876.00
1,08,337.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5,898.00
3,907.00
4,227.00
5,048.00
4,495.00
4,186.00
2,830.00
Selling and Distribution Expenses
1,96,997.00
2,11,316.00
2,25,305.00
1,99,534.00
2,06,877.00
1,93,149.00
1,99,499.00
Other Expenses
6,580.00
7,232.20
7,486.50
8,046.10
8,232.60
7,366.70
7,155.70
Total Expenditure (Excl Depreciation)
3,96,291.00
3,96,964.00
4,37,890.00
4,01,971.00
4,19,826.00
3,76,878.00
3,82,223.00
Operating Profit (PBDIT) excl Other Income
109503
62330
79518
60526
53298
37724
39709
Other Income
-11,595.00
1,768.00
-1,91,580.00
-16,452.00
-237.00
-79,498.00
-19,343.00
Operating Profit (PBDIT)
1,45,712.00
1,11,781.00
-60,898.00
94,091.00
1,03,329.00
6,869.00
67,350.00
Interest
5,898.00
3,907.00
4,227.00
5,048.00
4,495.00
4,186.00
2,830.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
3,78,198.00
3,49,875.00
3,83,915.00
3,45,569.00
3,46,996.00
3,08,726.00
3,13,595.00
Depreciation
47,804.00
47,683.00
51,164.00
50,017.00
50,268.00
48,643.00
46,984.00
Profit Before Tax
92,009.00
60,192.00
-1,16,290.00
39,028.00
48,566.00
-45,957.00
17,536.00
Tax
21,994.00
-14,342.00
-20,699.00
2,639.00
12,892.00
-15,384.00
2,800.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
68,422.00
74,896.00
-97,660.00
35,908.00
37,603.00
-33,278.00
14,513.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
68,422.00
74,896.00
-97,660.00
35,908.00
37,603.00
-33,278.00
14,513.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
68,422.00
74,896.00
-97,660.00
35,908.00
37,603.00
-33,278.00
14,513.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
14,81,792.00
15,13,255.00
14,93,809.00
15,29,842.00
16,76,442.00
15,95,988.00
15,03,255.00
Earnings per share (EPS)
38.11
41.73
-54.55
19.97
20.94
-18.56
8.06
Diluted Earnings per share
38.11
41.73
-54.55
19.97
20.94
-18.56
8.06
Operating Profit Margin (Excl OI)
21.65%
13.57%
15.37%
13.09%
11.27%
9.1%
9.41%
Gross Profit Margin
27.64%
23.49%
-12.59%
19.25%
20.89%
0.65%
15.29%
PAT Margin
13.53%
16.31%
-18.87%
7.76%
7.95%
-8.03%
3.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 6.91% vs 26.17% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 81.96% vs 13.50% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 51.89% vs 18.44% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 31.21% vs 65.26% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Astellas Pharma, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
5,05,794.00
11,06,685.00
-6,00,891.00
-54.30%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,05,794.00
11,06,685.00
-6,00,891.00
-54.30%
Raw Material Cost
1,27,596.00
5,16,313.00
-3,88,717.00
-75.29%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5,898.00
1,07,158.00
-1,01,260.00
-94.50%
Selling and Distribution Expenses
1,96,997.00
2,55,885.00
-58,888.00
-23.01%
Other Expenses
6,580.00
3,673.30
2,906.70
79.13%
Total Expenditure (Excl Depreciation)
3,96,291.00
9,16,089.00
-5,19,798.00
-56.74%
Operating Profit (PBDIT) excl Other Income
1,09,503.00
190,596.00
-81,093.00
-42.55%
Other Income
-11,595.00
67,727.00
-79,322.00
-117.12%
Operating Profit (PBDIT)
1,45,712.00
4,39,959.00
-2,94,247.00
-66.88%
Interest
5,898.00
1,07,158.00
-1,01,260.00
-94.50%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
3,78,198.00
5,90,372.00
-2,12,174.00
-35.94%
Depreciation
47,804.00
1,81,636.00
-1,33,832.00
-73.68%
Profit Before Tax
92,009.00
1,51,166.00
-59,157.00
-39.13%
Tax
21,994.00
26,351.00
-4,357.00
-16.53%
Provisions and contingencies
0
0
0.00
Profit After Tax
68,422.00
1,24,243.00
-55,821.00
-44.93%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
68,422.00
1,24,243.00
-55,821.00
-44.93%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
36.00
-36.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
68,422.00
1,24,279.00
-55,857.00
-44.94%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
14,81,792.00
68,65,259.00
-53,83,467.00
-78.42%
Earnings per share (EPS)
38.11
78.23
-40.12
-51.28%
Diluted Earnings per share
38.11
78.23
-40.12
-51.28%
Operating Profit Margin (Excl OI)
21.65%
17.22%
0.00
4.43%
Gross Profit Margin
27.64%
30.07%
0.00
-2.43%
PAT Margin
13.53%
11.23%
0.00
2.30%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 50,579.40 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 10.12% vs -11.23% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 6.91% vs 26.17% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6,842.20 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -8.64% vs 176.69% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 81.96% vs 13.50% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15,730.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 42.99% vs -15.82% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 51.89% vs 18.44% in Jun 2024

Quarterly - Interest
Interest 589.80 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 50.96% vs -7.57% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 31.21% vs 65.26% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.65%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."